IBOGFUniversal Ibogaine Inc.

About Universal Ibogaine Inc. (IBOGF)

Universal Ibogaine Inc. (IBOGF) is a Biotechnology company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the Pink tier.

Universal Ibogaine Inc. is a Canadian life sciences company with a mission to create a new standard in addiction treatment using ibogaine, a plant derived substance which has been proven to aid in detoxification from a variety of addictions.

Products and services

Universal Ibogaine Inc. (“UI”) is a Canadian life sciences company with a mission to create a new standard in addiction treatment using ibogaine, a plant derived substance which has been proven to aid in detoxification from a variety of addictions. UI obtained a public listing on Canada’s TSX Venture Exchange in October 2021. UI’s current business strategy involves two primary businesses: • Operation of an initial mental health and addiction treatment facility, The Kelburn Recovery Centre, which is located near Winnipeg Manitoba; and • Applying to conduct clinical trials research into the use of ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. UI is in process of developing an application to Health Canada to undertake a clinical trial in Canada to prove the safety and efficacy of ibogaine as an authorized addiction interruption medicine for the treatment of Opioid Use Disorder.

IBOGF key facts

Ticker symbol

IBOGF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Vancouver, BC, Canada

Country of incorporation

CA

Year of incorporation

2017

Employees

7

Estimated market cap

$6.14M (as of Apr 11, 2025)

Shares outstanding

308,610,516

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

7/31

Latest filing

Quarterly Report (Oct 31, 2022)

Universal Ibogaine Inc. leadership

• Nicholas Peter Karos — CEO
• Ian Rabb — COO
• Greg Leavens — CFO
• Stephen F.X. O'Neill — Securities Counsel
• Angela D. O'Neill — Legal Asst., Securities Counsel

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with I